Procure análises técnicas no nosso fórum aqui: Análises Técnicas
|Nota: Os dados após 2009-10-29 são ainda temporários e poderão por isso ter o valor de Abertura errado até nova actualização...|
Mudar para Gráfico Estático de Sepracor Inc.
| Sepracor Inc. - [Ticker: SEPR]|| |
|Última Trade||Range 52 Semanas||[0,000 - 0,000]|
|Hora da Última Trade||N/A - N/A||Price-Target 1 Ano||N/A|
|Variação|| ()||Capitalização Bolsista||3 |
|Bid / Ask||N/A||EPS||0,00|
|Volume||Volume Médio (3m)||0|
|Nota: Os dados podem apresentar atraso de alguns minutos.|
| Notícias sobre Sepracor Inc. [SEPR]: (ordenadas por relevância)|
|This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Directorate ChangeLondon South East (blog)... a member of the Board, at Vectura Group plc. Prior to this, he served as Chief Executive Officer and Chief Operating Officer at Critical Therapeutics Inc. and has also held senior management positions at Sepracor, Inc. (now Sunovion Pharmaceuticals ...
Pulmatrix (PULM) Appoints Dr. James Roach as CMOStreetInsider.comPulmatrix, Inc. (NASDAQ: PULM), today announced that it has appointed James (Jim) Roach, MD, FACP, FCCP as its new Chief Medical Officer, effective November 3, 2017. Dr. Roach will lead the clinical development of Pulmatrix's innovative inhaled drugs ...e mais »
Flex Pharma Reports Third Quarter 2017 Financial ResultsBusiness Wire (press release)Flex Pharma, Inc. (NASDAQ:FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments in Phase 2 randomized, controlled trials for cramps and spasticity associated with severe neurological diseases such as ...e mais »
Asthma Medication Market 2017: Global Industry Analysis, Top Company, Research Forecast, Analysis and Supply ...Newshawk TimeAsthma Medication Market Segment by Manufacturers: ? Dulera,QVAR,Glaxosmithkline plc,MAP Pharmaceuticals?Inc,Merck & Co. Inc,AstraZeneca plc,Roche Holdings Ltd,Genentech Inc,Sepracor, Inc,Schering-Plough Corp,Sanofi-Aventis,Theravance Inc ...e mais »
Desloratadine Sales Market Synthesis Healthcare, Clinical Reviews Reports 2017 to 2022Equity Insider (press release)These stakeholders include: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, ...e mais »
Form 8-K Acer Therapeutics Inc. For: Oct 02StreetInsider.comCAMBRIDGE, MA ? October 5, 2017 Acer Therapeutics Inc., (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet medical need, ...e mais »
|Para mais notícias sobre Sepracor Inc. clique aqui:|
Notícias de Sepracor Inc.